相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bone management in hematologic stem cell transplant recipients
D. L. Kendler et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
L. von Bahr et al.
BONE MARROW TRANSPLANTATION (2015)
Vitamin D Levels Affect Outcome in Pediatric Hematopoietic Stem Cell Transplantation
Magnus E. A. Hansson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation
Parameswaran Hari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density
Sunil Kota et al.
INDIAN JOURNAL OF ORTHOPAEDICS (2013)
Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
Siddhartha Ganguly et al.
CLINICAL TRANSPLANTATION (2012)
IOM Committee Members Respond to Endocrine Society Vitamin D Guideline
Clifford J. Rosen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation
Richard W. Joseph et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Vitamin D Level after Allogeneic Hematopoietic Stem Cell Transplant
Lisa Sproat et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Prevention of Fractures after Solid Organ Transplantation: A Meta-Analysis
Emily M. Stein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Decrease in Bone Mass in Women After Liver Transplantation: Associated Factors
L. F. Baccaro et al.
TRANSPLANTATION PROCEEDINGS (2011)
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens
Y. R. Abou-Mourad et al.
BONE MARROW TRANSPLANTATION (2010)
Plasma 25-Hydroxyvitamin D Levels and Fracture Risk in a Community-Based Cohort of Elderly Men in Sweden
Hakan Melhus et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
K. S. Baker et al.
LEUKEMIA (2010)
Prolonged Chronic Graft-versus-Host Disease is a Risk Factor for Thyroid Failure in Long-Term Survivors After Matched Sibling Donor Stem Cell Transplantation for Hematologic Malignancies
Bipin N. Savani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
HYPERPARATHYROIDISM AFTER IRRADIATION FOR CHILDHOOD MALIGNANCY
Todd McMullen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Approach to the Patient with Transplantation-Related Bone Loss
Peter R. Ebeling
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation
Bipin N. Savani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Normal long-term parathyroid function after autologous bone marrow transplantation in children
Per Frisk et al.
PEDIATRIC TRANSPLANTATION (2007)
Pamidronate reduces bone loss after allogeneic stem cell transplantation
A. P. Grigg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation
A. B. D'Souza et al.
INTERNAL MEDICINE JOURNAL (2006)
Endocrine disorders during the first year after autologous stem-cell transplant
L Tauchmanovà et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation
L Tauchmanovà et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Health-related quality of life after osteoporotic fractures
I Hallberg et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study
KS Baker et al.
BLOOD (2004)
The coming of age of radiation-induced hyperparathyroidism: Evolving patterns of thyroid and parathyroid disease after head and neck irradiation
AE Stephen et al.
SURGERY (2004)
Bone loss following hematopoietic stem cell transplantation: a long-term follow-up
CMS Schulte et al.
BLOOD (2004)
Thyroid, parathyroid, gonadal, and pancreatic β-cell function after bone marrow transplantation with chemotherapy-only conditioning
A Ghavamzadeh et al.
TRANSPLANTATION PROCEEDINGS (2003)
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation -: A single center experience and a review
L Tauchmanovà et al.
CANCER (2003)
Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study
MK Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies
L Tauchmanova et al.
OSTEOPOROSIS INTERNATIONAL (2003)
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases
L Tauchmanovà et al.
CANCER (2002)
The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis
TP van Staa et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation
K Kananen et al.
BONE MARROW TRANSPLANTATION (2002)
Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis
G Massenkeil et al.
LEUKEMIA (2001)
Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study
JM Stern et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)
AP Grigg et al.
BONE MARROW TRANSPLANTATION (2000)
Mechanisms of osteoporosis after hematopoietic cell transplantation
KN Weilbaecher
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study
A Kashyap et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study
C Schulte et al.
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
